Hemosol Inc., Dompe Farmaceuti S.p.A. sales and marketing update

The companies signed a memorandum of understanding under which Dompe will have exclusive rights to market HML's Hemolink in Southern and Eastern Europe. Dompe will invest C$5 million (US$3.27 million)...